SA
SCSCX logo
Touchstone Large Cap Focused Fund Class C(SCSCX)
Last print unknown agoAbout this dataData status
$75.08▼-0.17 (-0.23%)Stale · unknown old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 27.3 · elevated volatility

Overview →
SCSCX logo

SCSCX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-62.90%
SCSCX TTM EBITDA YoY % (30.43% → -62.90%)
High-resolution chart · PNG

What is ebitda growth?

Year-over-year EBITDA growth rate.

SCSCX ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Touchstone Large Cap Focused Fund Class C EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-62.897%
-37.1665%
-18.9825%
-1.1629%
2.6861%
4.3766%
-3.1603%
-2.6783%
1.0527%
-0.0575%
4.2801%
-12.0213%
-21.4783%
-17.5603%
2.8591%
63.2177%
83.2854%
59.6202%
4.5119%
-29.3848%
-29.9105%
-23.5888%
-5.0672%
3.0058%
-0.4783%
0.1438%
0.2848%
1.0205%
3.0433%
3.2273%
2.5378%
5.9794%
4.5838%
1.1759%
-3.2789%
-12.8219%
-7.1992%
-3.128%
11.4693%
21.6638%
11.59%
13.202%
30.4337%

Frequently asked questions: SCSCX ebitda growth

What is Touchstone Large Cap Focused Fund Class C (SCSCX)'s current ebitda growth?

Touchstone Large Cap Focused Fund Class C (SCSCX)'s latest reported ebitda growth (TTM) is -62.90% as of Sep 30, 2025. Year-over-year EBITDA growth rate.

How much historical ebitda growth data is available for SCSCX?

Stock Alarm Pro provides 43 dated trailing twelve months (ttm) observations for Touchstone Large Cap Focused Fund Class C (SCSCX)'s ebitda growth, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare SCSCX's ebitda growth to peers or set an alert?

You can open SCSCX's ebitda growth in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on SCSCX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.